Haemophilus B and hepatitis B vaccine explained
| Type: | combo |
| Component1: | Hib vaccine |
| Class1: | Vaccine |
| Component2: | Hepatitis B vaccine |
| Class2: | Vaccine |
| Tradename: | Comvax |
| Routes Of Administration: | Intramuscular |
| Atc Prefix: | J07 |
| Atc Suffix: | CA08 |
| Cas Number: | 820977-94-4 |
| Chemspiderid: | none |
Haemophilus B and hepatitis B vaccine is a combination vaccine whose generic name is Haemophilus b conjugate and hepatitis B recombinant vaccine.[1] It protects against the infectious diseases Haemophilus influenzae type B and hepatitis B.[2]
A branded formulation, Comvax, was marketed in the US by Merck.[3] [4] It was discontinued in 2014.[5]
Notes and References
- Web site: Comvax . https://web.archive.org/web/20240616072220/https://www.drugs.com/cons/comvax.html . 16 June 2024 . 15 July 2018 . Drugs.com.
- Web site: Haemophilus b conjugate and hepatitis b vaccine Intramuscular Advanced Patient Information . Drugs.com . 14 February 2020 . 13 September 2020.
- ((Centers for Disease Control and Prevention)) . FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine . MMWR Morb. Mortal. Wkly. Rep. . 46 . 5 . 107–9 . February 1997 . 9045037 .
- Web site: Comvax package insert. 15 July 2018.
- Zarei AE, Almehdar HA, Redwan EM . Hib Vaccines: Past, Present, and Future Perspectives . Journal of Immunology Research . 2016 . 7203587 . 2016 . 26904695 . 4745871 . 10.1155/2016/7203587 . free .
